Background and Purpose-Cerebral autoregulation may become impaired after stroke. To provide a review of the nature and extent of any autoregulation impairment after stroke and its course over time, a technique allowing repeated bedside measurements with good temporal resolution is required. Transcranial Doppler (TCD) in combination with continuous blood pressure measurements allows noninvasive continuous bedside investigation with high temporal resolution of the dynamic and the steady-state components of cerebral autoregulation. Therefore, this review focuses on all TCD studies on cerebral autoregulation in the setting of documented ischemic stroke. Methods-PubMed and EMBASE were searched for studies of stroke, autoregulation, and TCD. Studies were either acute phase (Ͻ96 hours after index stroke) or chronic phase (Ͼ96 hours after index stroke) autoregulation studies. Quality of studies was studied in a standardized fashion. Results-Twenty-three studies met the inclusion criteria. General agreement existed on cerebral autoregulation being impaired, even after minor stroke. Bilateral impairment of autoregulation was documented, particularly after lacunar stroke. Studies showed progressive deterioration of cerebral autoregulation in the first 5 days after stroke and recovery over the next 3 months. Impaired cerebral autoregulation as assessed by TCD was related to neurological deterioration, the necessity for decompressive surgery, and poor outcome. Synthesis of the data of various studies was, however, limited by studies not meeting key methodological criteria for observational studies. 
I
t is generally accepted that cerebral autoregulation may become impaired after stroke. 1 Autoregulation impairment in the presence of moderate to severe ischemia may render penumbral tissue particularly vulnerable to alterations in cerebral perfusion. It may be crucial in the survival of ischemic penumbra, especially during interventions in the stroke unit such as blood pressure (BP) manipulation or mobilization, and, as such, may confound trials of interventions in the stroke unit. Important research questions concern the reasons for cerebral autoregulation impairment, the nature of and the extent to which autoregulation becomes impaired, and how impairment progresses over time. Autoregulation is hypothesized to become impaired by damage to cerebral arterioles and capillaries during ischemia or other chronic insults (like hypertension). 2 Cessation of blood flow then rapidly initiates a related series of processes that effects endothelial cell and receptor dysfunction and smooth muscle activation, all leading to impaired vasoregulator function. 3 The primary focus of this review is on the nature and extent of cerebral autoregulation impairment and its course over time. For this, a definition of autoregulation and a description of various evaluation methods are required.
Cerebral autoregulation is the inherent ability of blood vessels to keep cerebral blood flow (CBF) relatively constant over a wide range of systemic BP levels by means of complex myogenic, neurogenic, and metabolic mechanisms. The CBF depends on vascular conductance and arterial blood pressure. Cerebral vascular tone is sensitive to arterial CO 2 . 4 In response to a variation in perfusion pressure, an adaptation in cerebrovascular resistance will cause CBF to return to its baseline. [5] [6] [7] [8] Evaluations of cerebral autoregulation have traditionally been performed under steady-state conditions: a measurement of CBF was obtained at a constant baseline BP and constant CBF, followed by another steady-state measurement after manipulation of BP. This "static" autoregulation was supposed to be intact if CBF was maintained at or near the baseline level despite BP changes. 9, 10 The group of Stirling used such "classic" steady-state methods to demonstrate different dysautoregulation responses to various anatomic ischemic locations, various risk factors, and duration after stroke. 11 Drawbacks of single steadystate evaluations are the vulnerability to confounding by spontaneous non-BP-related variability, such as CO 2 changes, 12 the time-consuming nature of procedures, the need for invasive pharmacological interventions, and the lack of information on any period of hypoperfusion possibly preceding the eventual return to stable perfusion. 6, 7 More recent developments, such as transcranial Doppler ultrasonography (TCD) and servo-controlled finger photoplethysmography, have offered the advantage of investigating beat-to-beat dynamics of the pressure-flow relationship of the cerebral circulation and of differentiating between fast and slow response mechanisms. 6, 7 This "dynamic" approach uses the induced or spontaneous rapid changes in BP as an autoregulatory stimulus and compares BP and CBF velocity (CBFV) during the whole autoregulatory process (dynamic pressure autoregulation). 5, 6, 13 Obviously, TCD can be used to study CBFV responses to steady-state changes in BP (static pressure autoregulation) 14, 15 and the autoregulatory reserve and adaptability after, for example, CO 2 inhalation or breathing maneuvers (chemical vasomotor autoregulation or cerebrovascular reactivity). 12 Although Stirling Meyer 16 found no correlation between the degree of static pressure dysautoregulation and impairment of chemical vasomotor autoregulation in stroke patients, many authors today interpret the isolated assessment of chemical vasomotor autoregulation as a steady-state method (ie, measurement at 2 static levels of CO 2 ). 17 Contrasting with the classical static autoregulation, no uniform method exists to provoke, measure, analyze, and report dynamic or chemical vasomotor autoregulation. Recently, some excellent articles 6 -8,18,19 provided an overview of the different methods to provoke hemodynamics and quantify pressure autoregulation using TCD. TCD studies are highlighted in this review because TCD studies allow evaluation of the steady-state and dynamic components of cerebral autoregulation, and because TCD together with finger photoplethysmography stands out as a technique with excellent temporal resolution, allowing noninvasive continuous bedside monitoring of CBFV and BP and, thus, autoregulation.
The central question of this review is what the nature and extent of autoregulation impairment after stroke as measured by TCD is. All 3 study approaches to cerebral autoregulation are considered: static pressure, dynamic pressure, and chemical vasomotor or combination autoregulation studies.
Materials and Methods

Study Identification
Cochrane Collaboration methodology for meta-analysis reviews modified for observational studies (www.equator-network.org) was used. 20 
Search Strategy
Studies were identified with a search strategy across 2 English language databases (Medline and Embase) between 1966 and October 2009 accommodating different MeSH terms or subcategories  available on each database (Table 1 and Supplemental material available online at http://stroke.ahajournals.org). Bibliographies of selected articles were screened for additional relevant articles.
Inclusion and Exclusion Criteria
Included were published TCD studies of human cerebral autoregulation after ischemic stroke. Eligibility was assessed by reading abstracts and, if necessary, whole articles. The effects of impaired cerebral autoregulation on neurological outcome were assessed. Excluded were case reports, non-English language articles, posterior territory stroke studies, and studies with ultrasound contrast agent injection. Carotid stenosis or known intracranial artery stenosis confounds the effect of stroke on cerebral autoregulation and was an additional reason for exclusion of studies.
Data Extraction
The following data were extracted: (1) stroke population; (2) stroke severity; (3) number of patients and controls; (4) acute (Ͻ96 hours after index stroke) vs chronic phase assessment (Ͼ96 hours after index stroke); (5) cerebral autoregulation challenges (input); (6) method of data analysis; (7) autoregulation evaluation method (steady-state vs dynamic autoregulation); (8) neurological outcome (Barthel score, NIHSS change, or necessity of craniectomy); (9) main conclusions of the authors; (10) presence, timing, and conclusion of follow-up studies; and (11) status of cerebral autoregulation in both hemispheres. Furthermore, important technical aspects of TCD observational studies such as bilateral probe recordings, reporting of CO 2 values, and use of continuous BP recording during the measurements were extracted.
Study quality was assessed using a checklist proposed previously for authors, editors, and reviewers of meta-analyses of observational studies. 20 This checklist was adapted to include 13 items relevant to TCD autoregulation observational studies (Table 2 and Supplemental material). 6 -8,13,18,19 
Results
Literature
Two-hundred thirty-eight publications met the search criteria and were evaluated. Inclusion criteria were met by 14 controlled studies and 13 observational studies. Three studies were excluded because of unclear timing of measurements after stroke onset, [21] [22] [23] and 1 was excluded because TIA and minor stroke patients were grouped together. 24 Hence, 23 publications were eligible for review. Study details are summarized in Tables 1 and 2 . Patient number ranged from 6 to 100. Sixteen studies included patients in the acute (range, 20 -96 hours) and 7 included patients in the chronic (range, 7-458 days) phase of stroke. Six studies had follow-up measurements between 3 days and 3 months after stroke. In 9 studies, the initial stroke severity was not reported, [25] [26] [27] [28] [29] [30] [31] [32] [33] and 8 studies failed to provide information about other clinical conditions (such as arrhythmias, diabetes mellitus, and carotid pathology) associated with impaired cerebral autoregulation. 25, 30, [32] [33] [34] [35] [36] [37] All studies allowed hypertensive patients to be included. In 2 studies, only information about the nonaffected hemisphere was presented because of permanent occlusion of contralateral middle cerebral artery. 32, 38 One study only provided information about the residual CBFV in the affected hemisphere. 34 Eleven studies reported the end-tidal CO 2 levels during the measurements. 25 ,31,36,38 -45 Six studies did not use continuous BP monitoring. 25, 27, 29, 34, 37, 45 One study included patients who received tissue plasminogen activator treatment. 41 Information about clinical course and outcome after acute stroke in relation to autoregulation was provided in 5 studies. 32, 33, 35, 41, 45 One study reported the correlation between cerebral autoregulation and outcome after stroke. 37 The Figure summarizes the different methods used to provoke cerebral hemodynamics and to assess autoregulation in the selected stroke studies. The median score on the proposed quality checklist for observational TCD autoregulation studies was 7 of 13 (range, 11), reflecting incomplete reporting of key methodological criteria in most studies.
Acute Stroke and Steady-State Autoregulation
Six of 8 studies found an impaired level of steady-state cerebral autoregulation in the acute phase of stroke. 31, 33, 34, 35, 37, 45 Two studies used passive head tilt testing in the range of 0°to 30°t o show that CBFV decreased at Ϸ20% in the 30°backrest compared to the supine position in patients with acute large hemispheric stroke. 34, 35 Three intensive care studies changed BP levels by slow catecholamine infusion, 33, 38 or by increasing intrathoracic pressure. 32 In these studies, patients could be identified as showing some level of impaired autoregulation. Schwarz et al 33 demonstrated an overall impaired autoregulation in their study population only when cerebral perfusion pressure increased by 30% compared with baseline. Although the high percentage of permanently occluded middle cerebral artery vessels in affected hemispheres makes comparison difficult, both studies by Schwarz et al 33, 35 found important changes in the nonaffected hemisphere, suggesting bilateral impaired autoregulation in large stroke. Comparison of patients who underwent decompressive surgery with those treated medically revealed greater impairment of autoregulation on the affected and contralateral sides in the operated group. 33, 35 Three studies used different tests to calculate cerebrovascular reactivity in the acute phase of stroke. Cupini et al 31 used the breath-holding index in different infarct types to show, particularly in 14 patients who already had multiple subcortical infarcts, impaired cerebrovascular reactivity in both hemispheres during the acute phase of a new stroke. Gur et al, 37 using slow infusion of acetazolamide in patients with moderate stroke, found impaired autoregulation in cortical strokes only. Bilateral nonsignificant impairment was detected in the subgroup of 24 patients with subcortical stroke, although no corrections were made for asymptomatic lacunar infarct status. Additionally, they failed to find a correlation between baseline severity, disability scores, and cerebrovascular reactivity. 37 Cerebrovascular reactivity measurement using 5% CO 2 inhalation in 100 minor stroke patients showed that impaired reserve capacity in the affected hemisphere was independently associated with early neurological deterioration within 72 hours. 45 
Acute Stroke and Dynamic Autoregulation
All studies are unanimous in their conclusion that dynamic pressure cerebral autoregulation is impaired in acute ACZ indicates acetazolamide; ARI, autoregulatory index; ATS, anterior territory stroke; BHI, breath-holding index; CA, cerebral autoregulation; CBFV, cerebral blood flow velocity; CPP, cerebral perfusion pressure; CVR, cerebrovascular resistance; HGM, handgrip method; HOBT, head of bed test; ICP, intracranial pressure; LAS, lacunar stroke; Mx, correlation index; NP, not performed; PEEP, positive end-expiratory pressure; PTS, posterior territory stroke; SBPF, spontaneous blood pressure fluctuations; TCM, thigh-cuff method; TFA, transfer function analysis. stroke, 30,41-44,46,47 particularly when stroke is moderate to severe, [41] [42] [43] [44] or after follow-up. 36, 41 In 5 studies, impaired autoregulation also could be demonstrated in the nonaffected hemisphere, [41] [42] [43] [44] which was particularly the case for first-ever lacunar stroke. 46 Eames et al 42 showed that these bilateral changes are unrelated to previous antihypertensive treatment, baseline BP levels, or BP changes after stroke, age, and stroke subtype or stroke severity. In 3 studies, dynamic cerebral autoregulation was recorded from spontaneous fluctuations of BP using the approaches of frequency domain (transfer function analysis [TFA] ) and time domain analysis. 36, 41, 46 In sum, TFA is a complex linear analysis to estimate the magnitude and the phase relationship between spontaneous or induced changes in BP and CBFV. 5, 48 In the time domain analysis, either the delay of CBFV counter-regulation during changes in BP or the degree of correlation between averaged CBFV and BP over time is used. 18, 46 Five studies calculated the autoregulatory index. 30, [42] [43] [44] 47 In sum, this is a linear curve-fitting procedure, which compares the CBFV response (measured directly or predicted) after a rapid step-like decrease in BP with a family of 10 theoretical flow-velocity curves to calculate dynamic cerebral autoregulation. 6, 10, 13 Two studies used rapid thigh-cuff method deflation as input challenges. 43, 44 Three studies used spontaneous BP changes to reconstruct (by inverse fast-Fourier transformation using TFA functions) 5,48 the (predicted) CBFV step response. 30, 42, 48 Comparable low-frequency ranges (0.06 -0.12 Hz) were used for TFA analyses.
Autoregulation seemed increasingly impaired in the first few days after a large stroke (mainly affected side) with unsuccessful thrombolysis 41 and did not improve in moderate stroke over the course of 2 weeks. 43 In minor stroke patients (after adjustment for covariates), cerebral autoregulation was similar to that in healthy controls after 2 weeks. 30, 47 
Chronic Phase of Stroke and Steady-State and Dynamic Autoregulation
Five of 7 studies found bilaterally impaired autoregulation between week 1 and 18 months after minor and moderate strokes. 25, [27] [28] [29] 40 Novak et al 39 only detected changes in the affected hemisphere of minor stroke patients, although the same group detected impaired dynamic autoregulation in both hemispheres during the Valsalva maneuver in 15 minor stroke patients using a nonlinear frequency shift method. 40 Gommer et al, 26 studying first-ever lacunar infarct, found TFA values and cerebrovascular reserve capacities in the normal range when examining their patients after Ն3 months. Information about stroke severity was not documented in this study. One research group repeated their initial measurements in the chronic phase and found some improvement after 3 months. 28 Three studies 26, 43, 44 included both steady-state and dynamic cerebral autoregulation measurements in the same patients and found disturbed dynamic autoregulation only.
Discussion
There seems to be general agreement that stroke is associated with impaired cerebral autoregulation, even in minor stroke. Cerebral autoregulation may become impaired in both hemispheres, although in some large stroke studies only measure- ments in the nonoccluded middle cerebral artery vessel (nonaffected hemisphere) were possible. Interestingly, this bilateral effect seems to be more pronounced in lacunar stroke. Two studies showed (some degree of) progressive impairment of cerebral autoregulation in the first days after stroke, which may affect the penumbral salvage. 36, 41 Cerebral autoregulation has been shown to recover over the next 3 months. Impaired cerebral autoregulation in stroke is related to acute neurological deterioration, necessity of decompressive surgery, and poor outcome. How the process of cerebral autoregulation progresses from impairment to improvement and which factors determine this process are unclear. Three studies investigated both dynamic and steady-state autoregulation and found dynamic impairment only. 26, 43, 44 This may be explained by differences in underlying mechanisms studied by dynamic vs steady-state investigation techniques, or simply by a greater sensitivity of dynamic investigation techniques for detection of stroke related autoregulation changes. The clinical relevance of such changes is unclear. In only 1 study with healthy subjects, dynamic measurement of cerebral autoregulation (with rapid cuff deflation) yielded results similar to classical static testing (phenylephrine infusion) under conditions of intact autoregulation and after pharmacologically induced impairment. 10 However, the evaluation of the "classical" lower limits of the cerebral pressure autoregulatory plateau requires considerable manipulations of BP, making the method invasive and potentially harmful for stroke patients. 12 Therefore, attention has been increasingly directed toward dynamic autoregulation. 6 -8,13 However, Zhang et al 15, 49 found that dynamic autoregulation may interact with changes in steady-state cerebrovascular resistance or vascular compliance or both leading to changes in dynamic autoregulation by TFA function. In this regard, a more comprehensive model to include both the autoregulatory mechanisms and steady-state vascular parameters should be explored to improve the precision of the model prediction. 15, 49 The interpretation of the TCD autoregulation studies is hampered by several methodological issues. First, studies using TCD rely on the assumption that changes in CBFV are directly proportional to changes in CBF. For that to be true, the cross-sectional area of the insonated artery needs to remain constant. 50, 51 For this reason, the results of any TCD study of cerebral autoregulation should always be interpreted with caution, keeping in mind the possibility that a change in middle cerebral artery diameter might have occurred. 7 Disadvantages of TCD compared to other techniques are the limited spatial resolution of the ultrasound images (not allowing a spatial allocation of impaired autoregulation to specific cortical areas). Although cerebral autoregulation initially has been studied and defined at the small vessel level in experimental animal models, it only can be defined in living humans in terms of measuring regional large vessel or whole brain blood flow. 52, 53 More specifically, the characterization of blood flow or velocity in a single vessel provides an approximation of the regional cerebral autoregulatory capacity. 14, 50, 54 It is also conceivable that the perfused territory of the insonated vessel might change under pathological conditions, such as focal ischemia or nonpathological conditions such as hypercapnia or hypocapnia and extreme hypoxia. 7 Furthermore, in Ϸ5% to 15% of the (stroke) patients, an insufficient acoustic bone window is present. Second, there is a lack of a clear definition of cerebral autoregulation, a gold standard technique for steady-state and dynamic cerebral autoregulation assessment, and a reference value for clinically relevant "impaired" cerebral autoregulation. 18 Together with great heterogeneity in study methods (Figure) , analytical methods and patient categories selected complicate comparing studies to a quality standard. Third, direct comparisons with other diagnostic techniques such as positron emission tomography and MRI are lacking because of major differences in temporal resolution. Also, there are several wellknown confounders of TCD assessment of cerebral autoregulation regulation, 13, 18, 55 some of which are difficult to control outside the intensive care unit setting. For example, with protocols involving changes in posture and observations set to as much as minutes apart, there is always the possibility of the pressure-velocity relationship being strongly affected by changes in physiological parameters like sympathetic activation, cerebral venous pressure, breathing frequency, and CO 2 levels. 13 Only 11 studies reported CO 2 levels during their measurements. Because CO 2 has a marked influence on CBFV and also on autoregulation itself, the interpretation of measurements can be severely confounded in situations in which significant changes in CO 2 go undetected. As already mentioned, changes in steady-state cerebrovascular resistance or vascular compliance or both, for example, during steady-state cerebral autoregulation may influence beat-to-beat changes in CBF independent of dynamic autoregulation. 15, 49 In addition, 6 studies (all steady-state) did not measure BP continuously. To determine autoregulation, BP ideally should be measured continuously. 6 Also, relatively small numbers of patients were studied, with even smaller numbers of control subjects recruited. 56 All these emphasize the importance of more complex models with a multivariate approach to take into account the contribution of other variables that can influence CBF regulation. 7, 8, 13 Finally, severe extracranial or intracranial artery stenosis and clinical conditions (eg, chronic hypertension, diabetes mellitus, and silent infarcts) may confound the assessment of cerebral autoregulation. 2, 17, 21, 23, 57 The effects of presence of collateral or cross-flow need to established in future studies. As an illustration, the finding of generally impaired autoregulation in lacunar stroke may be related to generalized small vessel disease attributable to chronic hypertension or diabetes. Longitudinal studies are required for lacunar stroke to show whether impaired cerebral autoregulation is a consequence of acute lacunar stroke or a correlate of widespread small vessel disease.
Additional knowledge is needed about the physiological and pathological determinants of cerebral autoregulation in stroke so that determinants of autoregulation can be better controlled for in future studies or taken into account with the help of multivariate (time and frequency domain) models. Until proven otherwise, it is possible that some clinical conditions disrupt myogenic mechanisms whereas others impair autoregulation by blocking metabolic or neurogenic pathways. 7 Dohmen et al 58 demonstrated impaired autoregulation in the peri-infarct tissue of large middle cerebral artery infarct patients who had malignant brain edema by studying the relation between perfusion pressure and local oxygen pressure (invasive monitoring), together with metabolic makers of brain damage (microdialysis). They stress the important issue of combining continuous monitoring of surrogate markers of CBF (like CBFV) with local brain information. 58 In that view, the use of (multichannel) near-infrared spectroscopy in stroke seems promising. 18, 59 Near-infrared spectroscopy is a noninvasive technique that allows continuous monitoring of cerebral hemoglobin oxygen desaturation, with a significant positive relationship between CBFV and near-infrared spectroscopy changes during clamping with carotid artery surgery. 60 Also, MRI with blood oxygen level-dependent signal is used to monitor dynamic autoregulation changes, with the benefit of allowing good spatial resolution. 61 
Conclusion
In summary, TCD appears to offer a practical bedside method with a high temporal resolution for cerebral autoregulation evaluation in stroke patients. TCD studies have shown impairment of cerebral autoregulation in various subtypes of ischemic stroke. In some patients, this impaired autoregulation is probably temporary and caused by the stroke; in others, it is preexisting and might have contributed to the stroke (eg, in chronic hypertension). In view of intervention studies in the stroke unit, such as the ongoing BP-lowering trials in acute stroke, correct identification of patients with impaired or adapted autoregulation may lead to the establishment of important subgroups in such trials. 62 Although some general conclusions can be drawn on the course of autoregulation over time, this topic requires further study. Variances in TCD study techniques, parameters, and interpretations limit further conclusions (Figure) . To improve the synthesis of data from various research groups (including stroke), there is great need for a uniform assessment of cerebral autoregulation in the whole field of autoregulation studies.
Future study goals are: (1) the determinants of cerebral autoregulation after stroke; (2) the development of multivariate models; (3) the status of both steady-state and dynamic autoregulation; (4) the course of cerebral autoregulation over time; and (5) the impact of cerebral autoregulation impairment on outcome with clinically relevant cut-off points. 
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